Haematomata, haematemesis, melenae, haematuria. Impaired, with gum bleeding, epistaxis, ecchymosis, 2.2 Summary of clinical effects If toxic amounts have been ingested, coagulation will be Potentially fatal gastrointestinal and intracerebral

SUMMARY 2.1 Main risks and target organs The target system is the haematological system, with (R)-(+)-isomer CAS number: NIOSH RTECS GN4550000 1.5 Brand names, Trade names 1.6 Manufacturers, Importers 2. NAME 1.1 Substance Warfarin 1.2 Group Coumarin derivative 1.3 Synonyms Coumadin Coumafene Zoocoumarin 1.4 Identification numbers 1.4.1 CAS number AUTHOR(S), REVIEWER (S), DATE (S) (INCLUDING UPDATES), COMPLETE ADDRESS (ES)ġ.

TOXICOLOGICAL ANALYSES & BIOMEDICAL INVESTIGATIONSĨ.1.2 Storage of laboratory samples & specimensĨ.1.3 Transport of laboratory samples &specimensĨ.2 Toxicological Analyses and Their InterpretationĨ.2.1 Tests on toxic ingredient(s) of materialĨ.2.1.2 Advanced Qualitative Confirmation Test(s)Ĩ.2.2.2 Advanced Qualitative Confirmation Test(s)Ĩ.2.3 Interpretation of toxicological analysesĨ.3 Biomedical investigations & their interpretationĨ.3.4 Interpretation of biomedical investigationsĩ.4 Systematic description of clinical effectsĩ.4.9 Eye, ears, nose, throat: local effectsĩ.4.12.2 Fluid & electrolyte disturbancesġ4. 2.4 First-aid measures and management principlesĦ.3 Biological half-life by route of exposureħ.2.5 Acceptable daily intake (ADI) and other guideline levelsĨ.

Antidote for coumadin toxicity